BiotechTube
Angelini Pharma

Angelini Pharma

Rome, Italy· Est.
angelinipharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Angelini Pharma is a century-old, private Italian pharmaceutical company with a significant international commercial footprint across Europe and the United States. Its strategy is built on a diversified portfolio spanning prescription drugs in Brain Health, Specialty Care, and over-the-counter Consumer Healthcare products. The company demonstrates a clear commitment to its core therapeutic areas through ongoing commercial initiatives, medical education platforms like Headway, and a pipeline that includes recently launched CNS products such as Ontozry.

Brain HealthMental HealthEpilepsyPainInfectious DiseasesOncologyConsumer HealthcarePrimary Care

Technology Platform

Integrated commercial and lifecycle management platform for in-licensed and acquired therapeutics; expertise in formulation and drug delivery for Consumer Healthcare products.

Opportunities

Growth in the Brain Health market driven by increasing diagnosis and unmet medical need, particularly for novel epilepsy treatments like Ontozry.
Expansion of its Consumer Healthcare portfolio through innovation and leveraging strong brand equity in self-care categories across Europe.
Potential for further in-licensing or acquisition of late-stage specialty assets to bolster its pipeline and leverage its commercial infrastructure.

Risk Factors

Significant pricing and reimbursement pressures across European healthcare systems, threatening profitability.
Reliance on in-licensing for innovative products creates dependency on partners and carries clinical and commercial integration risks.
Intense competition in both the prescription CNS market and the Consumer Healthcare OTC segment from larger multinational players.

Competitive Landscape

In Brain Health, Angelini competes with global CNS leaders like Johnson & Johnson, UCB, and Lundbeck, as well as generic manufacturers. In Consumer Healthcare, it faces giants such as Bayer, GSK, and Reckitt, alongside private-label brands. Its specialty care products compete in crowded hospital markets (oncology, anti-infectives) against large pharma and biotech companies, where differentiation and value proposition are critical.

More companies in Neuroscience & CNS →More companies in Italy →